471 related articles for article (PubMed ID: 3494198)
1. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
[TBL] [Abstract][Full Text] [Related]
2. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.
Ogushi F; Hubbard RC; Vogelmeier C; Fells GA; Crystal RG
J Clin Invest; 1991 Mar; 87(3):1060-5. PubMed ID: 1999486
[TBL] [Abstract][Full Text] [Related]
4. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
[TBL] [Abstract][Full Text] [Related]
5. [Long-term substitution in homozygous alpha 1-antitrypsin deficiency. Effect of the proteinase-antiproteinase equilibrium in plasma and sputum].
Braun J; Welle S; van Wees J; Winterhoff R; Wood WG; Dalhoff K; Wiessmann KJ
Dtsch Med Wochenschr; 1990 Jun; 115(23):889-94. PubMed ID: 2191843
[TBL] [Abstract][Full Text] [Related]
6. Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.
Hubbard RC; McElvaney NG; Sellers SE; Healy JT; Czerski DB; Crystal RG
J Clin Invest; 1989 Oct; 84(4):1349-54. PubMed ID: 2794066
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Am J Med; 1988 Jun; 84(6A):52-62. PubMed ID: 3289387
[TBL] [Abstract][Full Text] [Related]
8. Augmentation therapy of alpha 1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Eur Respir J Suppl; 1990 Mar; 9():44s-52s. PubMed ID: 2340051
[TBL] [Abstract][Full Text] [Related]
9. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
Martorana PA; Brand T; Gardi C; van Even P; de Santi MM; Calzoni P; Marcolongo P; Lungarella G
Lab Invest; 1993 Feb; 68(2):233-41. PubMed ID: 8441253
[TBL] [Abstract][Full Text] [Related]
10. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency.
Hubbard RC; Sellers S; Czerski D; Stephens L; Crystal RG
JAMA; 1988 Sep; 260(9):1259-64. PubMed ID: 3261353
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice.
Cavarra E; Martorana PA; Gambelli F; de Santi M; van Even P; Lungarella G
Lab Invest; 1996 Aug; 75(2):273-80. PubMed ID: 8765327
[TBL] [Abstract][Full Text] [Related]
12. Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy.
Wewers MD; Casolaro MA; Crystal RG
Am Rev Respir Dis; 1987 Mar; 135(3):539-43. PubMed ID: 3493719
[TBL] [Abstract][Full Text] [Related]
13. [Cigarette smoking and the etiopathogenesis of pulmonary emphysema].
Górecka D
Pneumonol Pol; 1984 Jul; 52(7):353-7. PubMed ID: 6387638
[No Abstract] [Full Text] [Related]
14. [Substitution therapy with alpha-1-Pi in patients with alpha-1-Pi deficiency and progressive pulmonary edema].
Konietzko N; Becker M; Schmidt EW; Rasche B; Ulmer WT; Ferlinz R; Lorenz J
Dtsch Med Wochenschr; 1988 Mar; 113(10):369-73. PubMed ID: 3280283
[TBL] [Abstract][Full Text] [Related]
15. Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin.
Hubbard RC; Brantly ML; Sellers SE; Mitchell ME; Crystal RG
Ann Intern Med; 1989 Aug; 111(3):206-12. PubMed ID: 2787611
[TBL] [Abstract][Full Text] [Related]
16. [Alpha 1-antitrypsin deficiency and emphysema. Replacement therapy?].
Johansen S; Gulsvik A
Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2142-5. PubMed ID: 2788939
[TBL] [Abstract][Full Text] [Related]
17. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.
Hubbard RC; Ogushi F; Fells GA; Cantin AM; Jallat S; Courtney M; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1289-95. PubMed ID: 2824559
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1-antitrypsin and other proteinase inhibitors.
Miravitlles M
Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503
[TBL] [Abstract][Full Text] [Related]
19. [Replacement therapy of emphysema caused by alpha 1-antitrypsin deficiency].
Vidal R; Miravitlles M; de Gracia X; Gallego B; Morell F
Med Clin (Barc); 1991 Feb; 96(5):180-2. PubMed ID: 2033989
[TBL] [Abstract][Full Text] [Related]
20. [A study of antielastase activity in the development of pulmonary emphysema in a family with alpha 1-antitrypsin deficiency].
Kishi F; Kakinoki A
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May; 27(5):565-70. PubMed ID: 2615095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
